These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9499119)

  • 1. Suppression of v-src transformation by the drs gene.
    Inoue H; Pan J; Hakura A
    J Virol; 1998 Mar; 72(3):2532-7. PubMed ID: 9499119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene.
    Yamashita A; Hakura A; Inoue H
    Oncogene; 1999 Aug; 18(34):4777-87. PubMed ID: 10490811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
    Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
    Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.
    Yoshioka N; Inoue H; Nakanishi K; Oka K; Yutsudo M; Yamashita A; Hakura A; Nojima H
    J Virol; 2000 Jan; 74(2):1008-13. PubMed ID: 10623765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epiderstatin induces the flat reversion of NRK cells transformed by temperature-sensitive Rous sarcoma virus.
    Osada H; Sasaki M; Sonoda T; Isono K
    Biosci Biotechnol Biochem; 1992 Nov; 56(11):1801-6. PubMed ID: 1369411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of fibronectin gene expression in v-src transformation.
    Gu H; Oliver N
    Exp Cell Res; 1995 Apr; 217(2):428-39. PubMed ID: 7698243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
    Verderame MF; Kaplan JM; Varmus HE
    J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
    Durkin JP; Whitfield JF
    J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the pRb-binding regions of E1A enables efficient transformation of primary epithelial cells by v-src.
    Fischer RS; Quinlan MP
    J Virol; 1998 Apr; 72(4):2815-24. PubMed ID: 9525601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia.
    Stoker AW; Hatier C; Bissell MJ
    J Cell Biol; 1990 Jul; 111(1):217-28. PubMed ID: 2164029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
    Maroney AC; Qureshi SA; Foster DA; Brugge JS
    Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit.
    Pierani A; Pouponnot C; Calothy G
    Mol Cell Biol; 1993 Jun; 13(6):3401-14. PubMed ID: 8388536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the catalytic domain of pp60v-src is responsible for the host- and temperature-dependent phenotype of the Rous sarcoma virus mutant tsLA33-1.
    Foster R; Martin GS
    Virology; 1992 Mar; 187(1):145-55. PubMed ID: 1310553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum independence of transcription from the promoter of an avian retrovirus in v-src-transformed cells is a primary, intracellular effect of increased tyrosine phosphorylation.
    Dutta A; Hamaguchi M; Hanafusa H
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):608-12. PubMed ID: 1689046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activity of c-Src and Csk in fibroblasts transformed by v-src oncogene.
    Tuhácková Z; Vojtechová M; Hlavácek J; Ruzzene M; Sovová V; Pinna LA
    Biochem Biophys Res Commun; 2002 Jan; 290(2):790-5. PubMed ID: 11785970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of drs mRNA in human colon adenocarcinomas.
    Shimakage M; Kawahara K; Kikkawa N; Sasagawa T; Yutsudo M; Inoue H
    Int J Cancer; 2000 Jul; 87(1):5-11. PubMed ID: 10861446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A host-dependent temperature-sensitive mutant of Rous sarcoma virus: evidence for host factors affecting transformation.
    Young JC; Liebl E; Martin GS
    Virology; 1988 Oct; 166(2):561-72. PubMed ID: 2845662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae.
    Florio M; Wilson LK; Trager JB; Thorner J; Martin GS
    Mol Biol Cell; 1994 Mar; 5(3):283-96. PubMed ID: 8049521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.
    Catling AD; Fincham VJ; Frame MC; Haefner B; Wyke JA
    J Virol; 1994 Jul; 68(7):4392-9. PubMed ID: 8207813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.